-
Vascular Health and Risk Management
-
Dr Pérez-López (Logout)
My Dovepress
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(1,472,188) Views
Editor in Chief Professor Roland Asmar
Acute coronary syndrome associated with Churg-Strauss syndromeAnnette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, et al
Emergency endovascular repair of acute descending thoracic aortic dissection
Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, Peter Kennedy
ISVH Society September Newsletter
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
Brandon A Van Noord, Andrew H Lin, Jeffery J Cavendish
Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function
Matthias Thielmann, Peter Hunold, Claudia Böhm, Parwis Massoudy, Heinz Jakob
Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia)
Demet Dogan Erol, Ibrahim Ozen
Determinants of outcome in patients eligible for thrombolysis for ischemic stroke
Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, et al
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A
Amy D Shapiro
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, et al
Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
John D Bisognano, Trent McLaughlin, Craig S Roberts, Simon SK Tang
Comprehensive cardiovascular risk management – what does it mean in practice?
Leif Erhardt, Robert Moller, Juan García Puig
Aldosterone antagonism in heart failure
Alan B Miller
Are pleiotropic effects of statins real?
Alberto Corsini, Nicola Ferri, Michele Cortellaro
Cholesterol lowering for secondary prevention: What statin dose should we use?
Kiranbir Josan, Finlay A McAlister
Ischemic preconditioning: Protection against myocardial necrosis and apoptosis
Efstathios K Iliodromitis, Antigone Lazou, Dimitrios Th Kremastinos
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus
WH Wilson Tang
Nebivolol in the treatment of chronic heart failure
Angie Veverka, Jennifer L Salinas
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
Man-Chiu Poon
Optimizing combination treatment in the management of type 2 diabetes
Giuseppe Derosa, Salvadeo Sibilla
Cardiovascular disease and osteoporosis: Balancing risk management
Darren ER Warburton, Crystal Whitney Nicol, Stephanie N Gatto, Shannon SD Bredin
Utilizing enoxaparin in the management of STEMI
Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale
Management of intracerebral hemorrhage
Ramandeep Sahni, Jesse Weinberger
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
FD Richard Hobbs
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
Mozhgan Dorkhan, Anders Frid
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Harold Bays, Peter H Jones
Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans
Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, et al
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University




